IL164221A0
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
69 members in 18 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 0204409 | France | A | |
| 0210846 | France | A | |
| 0301096 | France | W |
Members69
| Document | Office | Kind | |
|---|---|---|---|
| CA2480824A1 | Canada | A1 | |
| CA2480826A1 | Canada | A1 | |
| WO03084517A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03084518A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003246791A1 | Australia | A1 | |
| AU2003246792A1 | Australia | A1 | |
| FR2843880A1 | France | A1 | |
| FR2843881A1 | France | A1 | |
| WO03084517A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03084518A3 | World Intellectual Property Organization (WIPO) | A3 | |
| MXPA04009968A | Mexico | A | |
| MXPA04009979A | Mexico | A | |
| EP1492511A2 | European Patent Office (EPO) | A2 | |
| EP1492531A2 | European Patent Office (EPO) | A2 | |
| KR20050005437A | Republic of Korea | A | |
| KR20050005438A | Republic of Korea | A | |
| BR0309142A | Brazil | A | |
| BR0309093A | Brazil | A | |
| CN1652755A | China | A | |
| CN1652781A | China | A | |
| JP2005527572A | Japan | A | |
| JP2005527573A | Japan | A | |
| IL164221A0This record | Israel | A0 | |
| IL164222A0 | Israel | A0 | |
| HK1079448A1 | Hong Kong, China | A1 | |
| US2006110463A1 | United States of America | A1 | |
| FR2843880B1 | France | B1 | |
| FR2843881B1 | France | B1 | |
| ZA200407594B | South Africa | B | |
| ZA200407595B | South Africa | B | |
| US2006165807A1 | United States of America | A1 | |
| AU2003246792B2 | Australia | B2 | |
| EP1492531B1 | European Patent Office (EPO) | B1 | |
| AT407674T | Austria | T | |
| ATE407674T1 | Austria | T1 | |
| DE60323474D1 | Germany | D1 | |
| PT1492531E | Portugal | E | |
| EP1492511B1 | European Patent Office (EPO) | B1 | |
| AT419840T | Austria | T | |
| ATE419840T1 | Austria | T1 | |
| DE60325709D1 | Germany | D1 | |
| ES2314227T3 | Spain | T3 | |
| PT1492511E | Portugal | E | |
| ES2320438T3 | Spain | T3 | |
| CN100553625C | China | C | |
| CN100577164C | China | C | |
| US7906145B2 | United States of America | B2 | |
| US7910133B2 | United States of America | B2 | |
| US2011117205A1 | United States of America | A1 | |
| US2011129539A1 | United States of America | A1 | |
| JP4698950B2 | Japan | B2 | |
| JP4732696B2 | Japan | B2 | |
| IL164222A | Israel | A | |
| KR101061351B1 | Republic of Korea | B1 | |
| CA2480826C | Canada | C | |
| EP1492531B3 | European Patent Office (EPO) | B3 | |
| EP1492511B3 | European Patent Office (EPO) | B3 | |
| ES2314227T7 | Spain | T7 | |
| ES2320438T7 | Spain | T7 | |
| BRPI0309142B1 | Brazil | B1 | |
| US2015374635A1 | United States of America | A1 | |
| US2015374636A1 | United States of America | A1 | |
| BRPI0309142B8 | Brazil | B8 | |
| US2017281558A1 | United States of America | A1 | |
| BR122013000700B1 | Brazil | B1 | |
| US9814684B2 | United States of America | B2 | |
| US10004693B2 | United States of America | B2 | |
| BR122013000700B8 | Brazil | B8 | |
| BRPI0309142C1 | Brazil | C1 |
Numbers
- Application
- 16422103
Titles
- English
- Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
Classification
- CPC, 7
- A61K9/5015
- A61K9/50
- A61K9/5026
- A61K9/5047
- A61K31/43
- A61P31/04
- A61K9/10
- IPC, 11
- A61K9 50
- A61K9 10
- A61K31 43
- A61K47 12
- A61K47 14
- A61K47 26
- A61K47 32
- A61K47 34
- A61K47 38
- A61K47 44
- A61P31 04